Welcome to our dedicated page for Bioceres Crop Solutions SEC filings (Ticker: BIOX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Bioceres Crop Solutions Corp. filings document a foreign private issuer reporting through Form 6-K as a Form 20-F filer, with interim results, press releases and XBRL-tagged financial data prepared under IFRS. The disclosures cover revenue and margin trends by crop protection, seed and integrated products, and crop nutrition, along with currency risk, property and equipment, debt securities, bank borrowings, subsidiaries, joint ventures and associates.
The filing record also includes annual general meeting proxy materials, Nasdaq minimum bid-price correspondence, and material-event reports involving convertible and non-convertible note purchase agreements, acceleration notices, collateral matters and Pro Farm-related proceedings. Certain Form 6-K reports are incorporated by reference into Form F-3 and Form S-8 registration statements, linking current reports to the company's securities registration disclosures.
Bioceres Crop Solutions Corp. CEO and director Federico Trucco reported a bona fide gift transfer of 130,000 Ordinary Shares on 2026-05-20. The shares are held indirectly through Testamentario MQT Trust for the benefit of his child, and he disclaims beneficial ownership except for any pecuniary interest. Following the transaction, he also reports 226,000 Ordinary Shares held directly.
Bioceres Crop Solutions Corp. CEO and director Federico Trucco reported a bona fide gift transfer involving 150,000 Ordinary Shares on 2026-05-20, held indirectly through Testamentario MQT Trust for the benefit of his child. He disclaims beneficial ownership of these trust-held shares except for any pecuniary interest. Following the transactions, 150,000 Ordinary Shares are reported as held indirectly via the trust and 206,000 Ordinary Shares are reported as held directly.
Bioceres Crop Solutions Corp. reports that CFO Ezequiel Simmermacher received a grant of 375,000 Employee Stock Options (Right to Buy) covering 375,000 Ordinary Shares at an exercise price of 1.45 per share. The options were granted on August 3, 2026 under the 2023 Omnibus Equity Incentive Plan, vest annually in three equal installments commencing June 30, 2026, and expire on June 30, 2033. Following the grant, he holds 375,000 options directly.
Agriculture Investment Group Corp. and Granosur Holding Limited reported a reduced ownership stake in Bioceres Crop Solutions Corp. through Amendment No. 7 to Schedule 13D. They now beneficially own 3,722,732 ordinary shares, representing 5.83% of the company based on 63,815,891 shares outstanding as of December 31, 2025.
The change results from Granosur’s sale of an aggregate 676,711 shares, lowering the combined holdings to the current level. Between June 1 and July 2, 2026, the reporting persons sold shares in multiple open market transactions at prices generally between $0.32 and $0.49 per share, generating stated aggregate gross proceeds for each trading day.
Bioceres Crop Solutions updated its fiscal third-quarter 2026 results and disclosed an adverse court ruling. The company booked an additional $3.4 million provision under IAS 37 tied to contingent payments from past acquisitions. Third-quarter revenue from continuing operations was $39.4 million, down from $51.1 million, while net results swung to a $13.4 million loss from a $2.3 million profit and Adjusted EBITDA was $(0.6) million versus $9.1 million. Total financial debt was $227.8 million and net financial debt $212.9 million as of March 31, 2026, with equity falling to $91.7 million from $295.2 million as of June 30, 2025. Separately, a New York court granted plaintiffs partial summary judgment on liability under the company’s note purchase agreements, finding multiple events of default and valid acceleration; damages and related amounts will be determined later, and Bioceres continues to contest the case.
Agriculture Investment Group Corp. and its subsidiary Granosur Holding Limited reported a reduced beneficial stake in Bioceres Crop Solutions Corp. They now beneficially own 4,399,443 Ordinary Shares, equal to 6.89% of the class, based on 63,815,891 shares outstanding as of December 31, 2025.
The decrease reflects Granosur’s sale of an aggregate 673,262 shares in open market transactions between April 27 and May 29, 2026, at prices generally between $0.41 and $0.52 per share. The reporting persons state they currently have no specific plans for corporate actions regarding Bioceres but may change their intentions over time.
Bioceres Crop Solutions Corp. reports that its subsidiary Rizobacter Argentina S.A. has successfully completed an exchange offer and consent solicitation for several series of its notes. The transaction covers approximately US$42.7 million aggregate principal amount of existing notes.
Rizobacter obtained the required consents for its Series IX Class A and B Notes and Series X Class A and B Notes, with participation representing about 86% of the total outstanding principal amount. The exchange forms part of Rizobacter’s broader liability management and maturity extension efforts.
Bioceres Crop Solutions Corp. director Duraiswami Narain reported initial holdings of stock options representing the right to buy 150,000 Ordinary Shares. The options have an exercise price of $1.50 per share, become exercisable on June 30, 2028, and expire on June 30, 2033. All holdings in this filing are reported as held directly.
Bioceres Crop Solutions reported fiscal third quarter 2026 results showing weaker sales and profitability as it refocuses operations after exiting the Pro Farm business. Continuing-operations revenue was $39.4 million, down 23% year over year, with Crop Protection at $24.6 million, Seed and Integrated Products at $3.2 million, and Crop Nutrition at $11.6 million.
Gross profit fell to $12.7 million, and gross margin slipped from 35% to 32%, hurt by product mix and a non-recurring inoculant obsolescence adjustment. The company posted a net loss of $10.0 million versus a $2.3 million profit a year earlier, while Adjusted EBITDA moved from $9.1 million to $(0.6) million.
Bioceres reduced SG&A expenses by 16% to $16.1 million and continued cost and working-capital initiatives, but higher financial costs pushed total financial result to $(9.7) million. As of March 31, 2026, total debt was $228.8 million, net financial debt was $214.0 million, and cash and short-term investments were $14.8 million. Equity attributable to owners fell to $67.7 million, reflecting the earlier Pro Farm foreclosure and related ~$194 million derecognition of net assets and non-cash loss; the associated note acceleration remains under legal dispute.
Bioceres Crop Solutions Corp. CFO Ezequiel Simmermacher has filed an amended Form 3, which is the initial insider ownership report required for company officers. The amendment does not list any new stock transactions or derivative positions and instead updates previously reported ownership details.